clairop

IBS Symptom Tracking Before and After Treatment

Compare two equal windows of your own diary: days logged, symptom scores and daily impact. Here is the method, a worked example and what it can't prove.

Clairop Team23 min read

Photo: Thought Catalog / Unsplash

The short answer

To measure IBS symptom improvement, keep a baseline diary for about two weeks, then log the same way for an equal window after the change. Compare days logged, symptom-free days, symptom scores and daily impact. A before-and-after diary shows what changed, not why: placebo response, regression to the mean and natural ups and downs all look like treatment effect.

Trying to find your triggers? Clairop logs meals, symptoms and stool in seconds on iPhone, then flags foods your gut reacts to, including delayed reactions.

Get it on the App Store

You can tell whether an IBS change is helping by comparing two equal windows of your own diary: a baseline before the change and a follow-up after it, logged the same way. Count days logged, symptom-free days, symptom scores and how much IBS limited your day. That shows what changed. It cannot show why.

If you are reading this, you probably just started something: a diet trial, a new medicine, a course of therapy, a supplement, a different sleep routine. Three weeks later you are asking the question every person with IBS asks, which is "is this actually working, or am I fooling myself?" That is a fair question, and a vague feeling is a poor way to answer it. Memory flatters recent days and forgets old ones, so "I think I'm a bit better" can survive almost any reality.

This guide is treatment-agnostic. It does not matter whether you are changing food, taking a medicine your doctor prescribed, working with a therapist or trying something else. The measuring method is the same, and so are its limits. We will set out the method, work through an example with real arithmetic, and be honest about what a personal diary can and cannot tell you. For the score itself, our IBS severity score calculator holds the definitions and does the sums, so this page focuses on the workflow around it.

What does "improvement" actually mean in IBS?

Improvement in IBS means different things to different people, so decide your definition before you start. Researchers do the same. A 2025 scoping review of 408 IBS trials found outcomes fell into four main groups: global improvement (measured in about 77% of trials), individual symptoms (about 64%), quality of life (about 44%) and psychological status (about 24%) (Mo 2025).

That list is a good template for your own diary:

  • Global feeling. One question: compared with before, are things better, the same or worse?
  • Individual symptoms. Pain, bloating, stool form and frequency, urgency.
  • Daily impact. How much IBS stopped you doing things, from leaving the house to concentrating at work.
  • Mood and worry. Anxiety about the gut often moves with the gut.

Two people can both say "better" and mean opposite things. One has the same pain but fewer toilet dashes. The other has a calmer bowel but still cancels plans. Picking your priority up front stops you from marking a result as a win because one number moved while the one you care about did not.

The same review noted that abdominal pain and bloating are most often rated on 11-point (0 to 10) scales, and stool form on the Bristol Stool Form Scale (Mo 2025). Those are the tools we use below, because they are simple and they are what trials use.

How long should your baseline diary be?

Log for about two weeks before you start the change, and make the follow-up window the same length. We could not find a guideline that sets a minimum baseline, so treat two weeks as a practical suggestion. Two weeks covers at least one full IBS Symptom Severity Score window, which asks about the last 10 days (Francis 1997), and it usually spans a couple of weekends, a work pattern and sometimes part of a menstrual cycle.

Why equal windows matter:

  • Fair counts. "Four symptom-free days" means something different out of 7 than out of 14.
  • Same rhythm. If the baseline has two weekends and the follow-up has one, the comparison is quietly tilted.
  • Matching context. A baseline during exams and a follow-up during a holiday will show an "improvement" no treatment earned.

If your symptoms swing a lot, a third baseline week gives you a steadier picture of what "usual" is. If you are in the middle of a flare right now, write that on the first page. It matters, and we come back to it in the section on regression to the mean.

One practical point. Regulatory guidance for IBS drug trials leans on end-of-day diaries rather than weekly recall (Weerts 2020). You do not need a clinical trial's rigor, but the lesson carries over: a short entry made at the end of each day beats a weekly "how was it?" every time.

What should you record in both windows?

Record the same five items in both windows: whether you logged, pain, bloating, bowel pattern and daily impact. Keep the set small enough that you will still be doing it on day 13, because for measuring change these five do most of the work. For a fuller daily-impact log covering plans, work, sleep and food avoidance, see how to track IBS quality of life.

  1. Whether you logged that day at all. This sounds trivial, and it is the one most people skip.
  2. Pain, 0 to 10. Your worst or typical pain for the day. Choose one and stick with it.
  3. Bloating, 0 to 10. Same rule.
  4. Bowel pattern. Number of bowel movements and the Bristol type of each. The Bristol scale is a seven-type picture scale that tracks how fast stool moves through the gut (Lewis 1997), which makes it a better record than the words "loose" or "normal."
  5. Impact, 0 to 10. "How much did IBS limit what I wanted to do today?" This is the number that tends to matter most to real life, and it is the one clinics often miss.

Optional extras, only if they answer a question you actually have: urgency (yes or no), a sleep score, a note for a period, a stressful day or a new medicine. If you are also testing foods, our guide to keeping a food diary for IBS covers that separately, so you can keep this before-and-after record lean.

Our no-app tracking guide walks through sheet layouts, spreadsheet columns and a free-form timestamp trick if you want a template. The measuring method on this page works with any of them.

Why the wording and timing must stay identical

Retrospective ratings run higher than moments captured in real time. In a 230-person validation study, end-of-day scores were significantly higher than real-time scores for the same week (Bosman 2025). An earlier study found that patients overreported pain and stool frequency on diary cards compared with random momentary checks (Weinland 2011).

This does not mean diaries are useless. It means every number you write is slightly shaped by how and when you wrote it. If your baseline was filled in at bedtime and your follow-up was filled in the next morning for the day before, you have changed the instrument, and some of any difference is just the instrument. Pick one time of day and keep it.

Is a symptom-free day the same as a day you did not log?

No. A symptom-free day and a day you did not log are completely different things, and mixing them up is the commonest way to overstate improvement. Count symptom-free days only among days you actually logged, and report the missing days separately.

Here is why it matters. Imagine two weeks where you logged 11 days and 6 of them were symptom-free. Those 3 blank days could have been anything. Many people skip logging on bad days because they feel awful, or on very good days because they forgot IBS existed. You cannot know which, so you should not guess in your favor.

Do this instead:

  1. State the definition first. For example: a symptom-free day is one where pain and bloating were both 0 or 1 and you had no urgency or unplanned toilet trips. Write it at the top of the page and never change it midway.
  2. Report days logged out of days in the window. "11 of 14 days logged."
  3. Report symptom-free days out of days logged. "6 of 11."
  4. Show the range. The lowest plausible rate treats every blank day as a bad day: 6 of 14, or 43%. The highest treats every blank day as symptom-free: 9 of 14, or 64%. Your true rate sits somewhere in that range.
  5. Compare ranges, not single points. If the follow-up range does not overlap with the baseline range, that is a stronger signal than two raw percentages sitting near each other.

A downward trend in logging is information too. In an 8-week app-diary study of 189 people with IBS, mean adherence was about 88%, but it dropped as weeks went by, and the authors concluded the method might be less suitable for longer trials (Weerts 2020). If you find yourself logging fewer days in the follow-up window, that can reflect fatigue with tracking, or it can reflect feeling well enough to forget. Without the days, you cannot tell.

A short, honest note beats a perfect record. If you realize at 9 pm that you forgot to log, fill in what you can remember and mark it "late." A late entry is more useful than a gap, as long as it is labeled, because then you can leave it out of any comparison that depends on timing.

What does a before-and-after comparison look like in practice?

A worked example compares two equal windows using days logged, symptom-free days, average scores and daily impact. This invented one uses plain arithmetic so you can see the method end to end. Nothing here comes from a real person, and the numbers are chosen to be easy to follow.

The setup. Sam logged a 14-day baseline and then changed one thing. After four weeks on the change, Sam logged a second 14-day follow-up window. Sam used the same five items in both.

MeasureBaseline (14 days)Follow-up (14 days)
Days logged13 of 1411 of 14
Symptom-free days (of days logged)4 of 13 (31%)6 of 11 (55%)
Symptom-free range if blank days were all bad or all good4 to 5 of 14 (29% to 36%)6 to 9 of 14 (43% to 64%)
Average daily pain (logged days)5.03.5
Average daily bloating (logged days)5.04.0
Average daily impact, 0 to 105.53.5
Most common Bristol type65

Reading it in order:

  • Days logged fell from 13 to 11. That does not invalidate the comparison, but it widens the uncertainty, so we use the range row.
  • The ranges do not overlap. Even in the most pessimistic reading of the follow-up (43%), Sam is above the most optimistic baseline reading (36%). That is a stronger statement than comparing 31% with 55%.
  • Pain and impact moved most. Bloating moved least. That is a useful detail for a clinician, because "a bit better, mostly pain" is more actionable than "better."

Adding a validated score. At the start of each window Sam also filled in the IBS Symptom Severity Score using the free calculator. Its five items each run from 0 to 100: pain severity, how many of the last 10 days had pain (days times 10), bloating severity, dissatisfaction with bowel habit, and interference with life. The total runs to 500 (Francis 1997).

Item (out of 100)BaselineFollow-up
Pain severity5540
Pain frequency (6 days vs 4 days, times 10)6040
Bloating severity5040
Bowel dissatisfaction7050
Interference with life6040
Total (out of 500)295210

The total fell by 85 points. The scale's authors reported that a change of 50 reliably indicated improvement (Francis 1997), so 85 clears that bar. In the scale's bands, 295 is moderate (175 to 299) and 210 is still moderate, so Sam moved down within a band without leaving it. That detail is worth saying out loud to a doctor: "better, but still moderate."

How the score bands and its scoring are defined is the calculator's job, so we keep definitions there and do not repeat them in full here.

What this example does and does not show

Sam's diary shows a consistent, multi-measure improvement between two windows. It does not show that the change Sam made caused it. That is the subject of the next section, and it is the part most before-and-after guides skip.

Why a before-and-after diary cannot prove a treatment worked

A before-and-after diary cannot prove a treatment worked because it has no comparison group, so placebo response, regression to the mean and natural ups and downs can all produce an apparent improvement. This is the honest limit of the method, and you are better off knowing it.

Regression to the mean

Regression to the mean is the tendency for unusually extreme measurements to be followed by more ordinary ones. It "can make natural variation in repeated data look like real change," and its effect grows when you only look at follow-up after a high baseline (Barnett 2005).

Translate that to IBS. Most people start something new when symptoms are at their worst, because a bad patch is what pushes you to act. Even if you did nothing, the next stretch would probably be milder. The diary then records "improvement" that is partly just the bad patch ending. The bigger the flare at baseline, the bigger the flattering effect.

Natural ups and downs

IBS is not a steady condition. In a 12-year population study of functional bowel and stomach disorders, among people with symptoms at the first survey, about 20% had the same symptoms at the end, 40% had none, and 40% had different symptoms (Halder 2007). That study used annual surveys over many years rather than weekly diaries, so it describes the long-run churn, not your next month. Still, it is a reminder that symptoms come and go, and sometimes change shape, with no obvious reason.

Episodes also cluster. In a study that sampled people with IBS at random moments through the day, about a third of the time was spent in symptom episodes, with pain the strongest marker of an episode (Weinland 2011). A 14-day window can easily catch you in the middle of a cluster or between two.

Placebo response

Placebo response in IBS is large. A meta-analysis of 73 randomized trials, covering 8,364 people given placebo, found a pooled placebo response rate of 37.5%, with higher rates in trials with shorter durations and physician-reported outcomes (Ford 2010). So roughly one in three people given an inactive treatment in those trials reported improvement.

Even knowing it is a placebo does not remove the effect. In a 3-week randomized trial of 80 people with IBS, open-label placebo pills, labeled as inert, produced greater global improvement and lower symptom severity scores than no treatment (Kaptchuk 2010). That trial was small and single-center, so we should not oversell it. The cautious reading is that doing something, expecting to improve and having a caring routine can all move subjective symptoms.

A broader Cochrane review found that placebo interventions in general do not have important clinical effects, but can influence patient-reported outcomes such as pain, and it is difficult to distinguish patient-reported placebo effects from biased reporting (Hróbjartsson 2010). IBS outcomes are exactly that kind: self-reported, subjective and symptom-led.

None of this means a treatment that helps you is "just placebo," and it certainly does not mean you should stop something that is working. It means your diary cannot separate a drug or diet effect from the hopeful, attentive routine around it. That separation needs a controlled trial.

Other things that changed at the same time

When you start a treatment you often change several things at once: you eat more carefully, sleep better because you feel in control, exercise, cut caffeine, or add a probiotic "just in case." Any of those can move your score. A diary has no way to attribute the change among them.

A baseline that is too easy to beat

Baseline severity also shapes how likely you are to call something a success. In a 289-person treatment trial, the proportion reporting adequate relief at 3 weeks was 70% in the mild group, about 50% in the moderate group and 39% in the severe group, among people given sham acupuncture or wait-list control (Passos 2009). Whether you "feel adequately relieved" depends partly on where you started, not just on what you did. Mention your baseline band whenever you describe your result.

How big a change is big enough?

For the IBS Symptom Severity Score, the authors of the original scale reported that a change of 50 points reliably indicated improvement (Francis 1997). That is a sensible threshold for noticing change over a few weeks, with two cautions.

  • It is not a verdict on the treatment. It tells you the score changed by more than day-to-day wobble in the original validation, not that your treatment caused it.
  • It is one scale. If you track pain on a 0 to 10 scale, there is no equally established personal threshold. In IBS-C drug trials, a roughly 29% improvement in abdominal pain was associated with feeling adequately relieved, but that figure came from group data in a specific condition and is not a personal target (Camilleri 2015).

A practical rule for personal use: look for movement in the same direction across several measures (symptom-free days, pain, impact, score), not a single dramatic number. Agreement among measures is harder to explain by chance than one lucky average.

What if the numbers say "no change"?

No change is a result. It can mean the treatment is not helping you, that it needs longer than you gave it, or that your symptoms are too variable for two weeks to show a difference. Ask your prescriber or dietitian how long a fair trial lasts for what you are doing, write the answer on the first page, and agree in advance what you will do if the numbers have not moved by then. Do not stop or change a prescribed medicine on the strength of a diary alone. Raise it with the person who prescribed it.

How can you make the comparison fairer?

You can make a diary comparison fairer by fixing your plan, scales and window lengths in advance and changing one thing at a time. A diary cannot become a trial, but these seven steps remove the most avoidable errors, and all of them cost nothing.

  1. Change one thing at a time. If you must change two, note both and accept you cannot separate them.
  2. Write the plan first. Your definition of a symptom-free day, your window lengths and your "what would count as better" rule should exist before you see any results.
  3. Note the starting context. Flare, stress peak, period, holiday, illness, new medicine. A few words each.
  4. Keep the instrument fixed. Same time of day, same scales, same wording.
  5. Look at the shape, not just the average. A trend that improves steadily across the follow-up is more convincing than one lucky week.
  6. Re-measure later. A second follow-up a few weeks on tells you whether the change held or was a blip. A single follow-up cannot.
  7. Do not unblind yourself selectively. Calculate your averages before deciding whether the story is good or bad, not after.

Only your clinician can design a proper trial of one treatment against another for you, and sometimes that happens: for example, a planned, supervised break from something to see whether symptoms return. Do not stop a medicine or supplement to test it without agreement from the person who prescribed it.

Does this method work for diet, medicines and therapy alike?

Yes, the same before-and-after method works for diet, medicines and therapy, but what counts as a fair window differs by treatment and is not ours to set.

Diets, medicines and psychological therapies work on different timescales, and what a "fair trial" looks like depends on the specific treatment. Both the British and American guidelines treat IBS as a disorder of gut-brain interaction managed through dietary, drug and psychological options (Vasant 2021, Lacy 2021), and your clinician can tell you what is reasonable for yours. If diet and hypnotherapy overlap, low FODMAP and gut-directed hypnotherapy together shows how to keep the two changes apart on one timeline, and Clairop vs Nerva explains how a diary and a therapy program fit together.

A few things to add for specific cases:

  • Diet changes. Record adherence ("followed it fully, mostly or not at all today") alongside symptoms, because a diet you only half followed can look ineffective or effective for the wrong reasons. Our guide to why a food diary can show no pattern explains the usual traps.
  • Therapies such as CBT or gut-directed hypnotherapy. Effects tend to build over sessions rather than appear at once, so the daily numbers may lag. See what the evidence says in our posts on whether CBT works for IBS and gut-directed hypnotherapy.
  • Combining approaches. If you are doing a diet and a therapy together, the diary shows the combined effect only. That is fine for deciding whether you feel better, and it is a limit on attributing credit.

How do you take a before-and-after diary to your doctor?

Bring a one-page summary rather than a stack of daily sheets. Clinicians have minutes, and a short comparison lets them see whether to continue, adjust or investigate further. If the review is with a dietitian, the dietitian follow-up diary gives a filled-in one-page layout. Include:

  • The two window dates and what changed between them.
  • Days logged in each window, and symptom-free days out of days logged.
  • Average pain, bloating and impact for each window, and your IBS Symptom Severity Score at the start and end.
  • Your single biggest remaining problem, in one sentence.
  • Anything on your red-flag list (below).

Our guides on preparing for a GI appointment and how to describe stomach pain cover what to say alongside the numbers. If you use Clairop, it is built around logging in seconds and producing a one-page summary to take to an appointment (see how it works), but the same page can be made on paper. Clairop does not diagnose or treat anything, and it does not tell you whether a treatment is working. That judgment is yours and your clinician's.

Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.

Download on the App Store

When does tracking get in the way?

Tracking is a tool for answering a question, not a permanent duty. If checking your numbers is making you more anxious about every twinge, shrink the diary to one daily rating and one line of notes, set an end date, or take a break. People in IBS communities often describe both experiences: some say tracking calmed them by replacing worry with data, others say it made them hypervigilant. Both reactions are common.

A before-and-after comparison is also a poor fit if you are in the middle of a severe flare, or if you are changing your regimen every few days. In those cases the useful record is the simple daily log you would show a doctor, not a formal comparison.

Common myths about measuring IBS improvement

"If I feel better, it worked." You may well be better, and that matters. But feeling better does not tell you the cause, as the placebo, regression and natural-variation evidence above shows.

"No symptoms logged means a good day." A blank day is a missing day. Count it separately.

"One good week proves it." Symptoms cluster and fluctuate, so a single good week is weak evidence. Look for a sustained shift across a whole window.

"The score is the goal." The IBS Symptom Severity Score is a measuring stick. A lower number is only useful if you also function better. Aim for the life you want, not a number.

"A big improvement means I should stop tracking." Changes can fade. A short follow-up check later on tells you whether the gain held.

"The diary can replace tests." It cannot. A diary tracks what you notice. It cannot rule out other conditions.

When should you see a doctor instead of tracking?

Do not keep diarying through symptoms that need checking. See a doctor promptly if you notice any of these, whatever your score says:

  • Blood in your stool, or black stools
  • Unexplained weight loss
  • Fever
  • Symptoms that wake you at night
  • Anemia, or feeling unusually tired and pale
  • Symptoms that start after age 50
  • A family history of bowel cancer, inflammatory bowel disease or ovarian cancer
  • A new, persistent change in bowel habit, or symptoms that are steadily getting worse

Also see your doctor if the diary shows no improvement after the time your clinician said a fair trial would take, or if bad days are getting more severe even as they get rarer.

This guide is for IBS. If you have Crohn's disease or ulcerative colitis, the IBS Symptom Severity Score is the wrong yardstick, and disease control is judged with different measures and tests that only your care team can interpret. Our guide to what to track in an IBD symptom diary covers that case.

The short version

  1. Log a baseline of about two weeks before the change, then an equal follow-up window, with identical questions and timing.
  2. Compare days logged, symptom-free days (out of days logged), pain, bloating, bowel pattern and daily impact. Show the best-case and worst-case range for missing days.
  3. Add the IBS Symptom Severity Score at the start and end. A fall of 50 points was the original authors' marker of improvement.
  4. Treat the result as a description of change, not proof of cause. Placebo response, regression to the mean, natural fluctuation and parallel changes can all produce an apparent win.
  5. Ask your prescriber or dietitian how long a fair trial lasts, and never stop a prescribed treatment on the strength of a diary alone.
  6. Take a one-page comparison to your doctor, and flag any red-flag symptom straight away.

Our broader guide to tracking IBS symptoms without an app covers the sheets and spreadsheets for building this record, and our best IBS apps list compares tools if you prefer one. If you are trying to work out whether a rough patch is a flare rather than a treatment effect, start with how to tell whether your IBS is flaring.

Frequently asked questions

How do I know if my IBS treatment is working?
Compare two equal windows of your own diary, one before the change and one after, using the same questions each time. Look at days logged, symptom-free days, your average pain, bloating and bowel scores, and how much IBS got in the way of your day. A clear, sustained shift across several of these is encouraging, but a diary alone cannot tell you the treatment caused it.
How long should I track IBS symptoms before starting a treatment?
We found no guideline that sets a minimum, so this is a practical suggestion rather than a rule. About two weeks gives you at least one full IBS Symptom Severity Score window, which asks about the last 10 days, and it shows some ups and downs. If your symptoms swing a lot week to week, a third week gives a steadier baseline.
What is a good way to measure IBS symptom improvement?
Use the same simple measures in both windows. A daily 0 to 10 rating for pain and bloating, a Bristol stool type for each bowel movement, a yes or no for a symptom-free day, and a daily 0 to 10 rating of how much IBS limited you. Add one validated score, such as the IBS Symptom Severity Score, at the start and the end.
How many points does the IBS Symptom Severity Score need to fall to count as improvement?
The scale's authors found that a change of 50 points reliably indicated improvement. That figure comes from the original 1997 validation work and describes a change in the score, not proof that a treatment caused it. Treat 50 points as a sensible rule of thumb for noticing change, then confirm with how you feel and function.
What counts as a symptom-free day?
Decide before you start and keep the definition the same. A common choice is a day where pain and bloating are both 0 to 1 out of 10 and you had no urgency or unplanned toilet trips. A day you did not log is not a symptom-free day. It is a missing day, and it should be counted separately.
Should I count days I forgot to log as good days?
No. Silent days are often neither good nor bad, and treating them as good days can inflate your improvement. Report days logged out of days in the window, work out your symptom-free days on the days you did log, and also show the best-case and worst-case range if the missing days had all been bad or all been good.
Can a symptom diary prove a treatment worked?
No. A diary shows what changed, not why. Without a comparison group, improvement can come from the treatment, but also from placebo response, regression to the mean, natural ups and downs, or other changes you made at the same time. A diary is still very useful for you and your clinician to judge whether to continue.
What is regression to the mean in IBS tracking?
It is the tendency for an unusually bad stretch to be followed by a milder one even if nothing changes. People often start a treatment when symptoms are at their worst, so the follow-up window looks better partly by chance. Starting your baseline during a flare makes this effect larger, so note it on the page.
How long should I wait before judging a treatment?
It depends on the treatment, and your prescriber or dietitian is the right person to say. Diets, medicines and therapies work on different timescales, and stopping early can mean judging before an effect could appear. Ask at the start how long a fair trial lasts, write the answer on your diary, and agree what result would make you carry on.
Is IBS getting better if I have fewer bad days but the bad days are worse?
Not necessarily. Frequency and severity can move in opposite directions, which is why a single number can mislead. Track both: how many days had symptoms and how bad the worst days were. If bad days are rarer but harder, tell your doctor, because the picture is mixed rather than simply better.
Do I need an app to track before and after?
No. A paper sheet or spreadsheet works if you use identical columns in both windows and write entries close to when things happen. Apps make it easier to log in seconds and to see a summary. The method matters more than the medium, and our no-app guide shows how to set up each.
Do these steps work for Crohn's disease or ulcerative colitis?
The window and logging principles apply, but IBS scores are not the right yardstick for inflammatory bowel disease. IBD care uses different measures and tests, such as bloods, stool tests and scopes, which only your care team can interpret. Use your diary to prepare for appointments rather than to judge disease control yourself.

Sources

  1. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395-402. doi:10.1046/j.1365-2036.1997.142318000.x
  2. Weerts ZZRM, Heinen KGE, Masclee AAM, Quanjel ABA, Winkens B, Vork L, et al. Smart data collection for the assessment of treatment effects in irritable bowel syndrome: observational study. JMIR Mhealth Uhealth. 2020;8(11):e19696. doi:10.2196/19696
  3. Mo JH, Zeng P, Zhou LL, Xia BQ, Yang XB, Li Q. Outcome measures for irritable bowel syndrome: a scoping review. BMC Med Res Methodol. 2025;25(1):279. doi:10.1186/s12874-025-02718-8
  4. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920-4. doi:10.3109/00365529709011203
  5. Bosman M, Vork L, Jonkers D, Snijkers J, Topan R, Aziz Q, et al. Results from a psychometric validation study: patients with irritable bowel syndrome report higher symptom burden using end-of-day vs real-time assessment. Am J Gastroenterol. 2025;120(5):1098-107. doi:10.14309/ajg.0000000000003091
  6. Weinland SR, Morris CB, Hu Y, Leserman J, Bangdiwala SI, Drossman DA. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment. Am J Gastroenterol. 2011;106(10):1813-20. doi:10.1038/ajg.2011.170
  7. Passos MC, Lembo AJ, Conboy LA, Kaptchuk TJ, Kelly JM, Quilty MT, et al. Adequate relief in a treatment trial with IBS patients: a prospective assessment. Am J Gastroenterol. 2009;104(4):912-9. doi:10.1038/ajg.2009.13
  8. Camilleri M, Lembo AJ, Lavins BJ, MacDougall JE, Carson RT, Williams V, et al. Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-C. United European Gastroenterol J. 2015;3(1):53-62. doi:10.1177/2050640614555946
  9. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2005;34(1):215-20. doi:10.1093/ije/dyh299
  10. Halder SL, Locke GR, Schleck CD, Zinsmeister AR, Melton LJ, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007;133(3):799-807. doi:10.1053/j.gastro.2007.06.010
  11. Ford AC, Moayyedi P. Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther. 2010;32(2):144-58. doi:10.1111/j.1365-2036.2010.04328.x
  12. Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One. 2010;5(12):e15591. doi:10.1371/journal.pone.0015591
  13. Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev. 2010;(1):CD003974. doi:10.1002/14651858.CD003974.pub3
  14. Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021;70(7):1214-40. doi:10.1136/gutjnl-2021-324598
  15. Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17-44. doi:10.14309/ajg.0000000000001036

Clairop is a general wellness app for people living with a diagnosed digestive condition. It does not replace professional medical care, diagnosis, or treatment. Always follow your healthcare provider's advice.

Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.

Download on the App Store

Apps for this, ranked

Free tools